C6ORF89 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.274800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.926800E-01
Normal-vs-Stage2
2.774200E-01
Normal-vs-Stage3
3.427900E-02
Normal-vs-Stage4
7.083200E-01
Stage1-vs-Stage2
8.373800E-02
Stage1-vs-Stage3
4.002300E-02
Stage1-vs-Stage4
7.601600E-01
Stage2-vs-Stage3
1.757020E-01
Stage2-vs-Stage4
6.233800E-02
Stage3-vs-Stage4
5.863800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.387000E-01
Normal-vs-AfricanAmerican
6.816000E-01
Normal-vs-Asian
2.236800E-01
Caucasian-vs-AfricanAmerican
5.858000E-01
Caucasian-vs-Asian
3.198200E-01
AfricanAmerican-vs-Asian
2.671400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.908200E-01
Normal-vs-Female
4.860800E-01
Male-vs-Female
6.819200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.958800E-01
Normal-vs-Age(41-60Yrs)
6.418200E-01
Normal-vs-Age(61-80Yrs)
3.384800E-01
Normal-vs-Age(81-100Yrs)
4.573400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.543800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.144000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.505000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.672400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.615000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.720000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.281450E-01
Normal-vs-Daily Drinker
1.131550E-02
Normal-vs-Weekly Drinker
3.439600E-01
Normal-vs-Occasional Drinker
9.342200E-01
Normal-vs-Social Drinker
8.034400E-01
Non Drinker-vs-Daily Drinker
1.742450E-01
Non Drinker-vs-Weekly Drinker
2.990600E-01
Non Drinker-vs-Occasional Drinker
6.447800E-02
Non Drinker-vs-Social Drinker
6.614200E-02
Daily Drinker-vs-Weekly Drinker
2.353800E-02
Daily Drinker-vs-Occasional Drinker
1.034060E-02
Daily Drinker-vs-Social Drinker
1.905690E-02
Weekly Drinker-vs-Occasional Drinker
3.248400E-01
Weekly Drinker-vs-Social Drinker
4.410800E-01
Occasional Drinker-vs-Social Drinker
8.025000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.379000E-01
Normal-vs-Grade 2
9.426500E-02
Normal-vs-Grade 3
1.241370E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.162800E-01
Grade 1-vs-Grade 3
3.688200E-01
Grade 1-vs-Grade 4
2.379000E-01
Grade 2-vs-Grade 3
9.184800E-01
Grade 2-vs-Grade 4
9.426500E-02
Grade 3-vs-Grade 4
1.241370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.619200E-01
Normal-vs-NonDiabetic
3.479200E-01
Diabetic-vs-NonDiabetic
5.320000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.878200E-02
Normal-vs-NoPancreatitis
3.764800E-01
Pancreatitis-vs-NoPancreatitis
4.220400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.329600E-01
Normal-vs-N1
2.856600E-01
N0-vs-N1
2.194600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.653200E-01
Normal-vs-TP53-NonMutant
9.661400E-01
TP53-Mutant-vs-TP53-NonMutant
3.094400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
